 |
Selected news stories and interviews
about our research
|
Why people cheat in sports, banking and science, according to guest columists Dr. Ferric C. Fang and Dr. Arturo Casadevall...
Male scientists are far more likely to commit fraud than females and the fraud occurs across the career spectrum,
from trainees to senior faculty. The analysis of professional misconduct was co-led by a researcher at Albert Einstein College
of Medicine of Yeshiva University and was published today in the online journal mBio...
Scientists at Albert Einstein College of Medicine of Yeshiva University have been awarded two
Grand Challenges Explorations (GCE) grants from Bill & Melinda Gates Foundation for their
innovative global health and development research projects...
In sharp contrast to previous studies suggesting that errors account for the majority of
retracted scientific papers, a new analysis - the most comprehensive of its kind - has found that
misconduct is responsible for two-thirds of all retractions...
On August 10, 2011, Dr. Arturo Casadevall has published his 500th peer-reviewed paper in the field of
of biomedical sciences. To celebrate this special occasion and recognize this extraordinary achievement, the
Casadevall Lab members presented handmade trophy and certificate to their boss...
Arturo Casadevall, MD. Ph.D., and Ekaterina Dadachova, Ph.D., of Albert Einstein College of Medicine of Yeshiva
University have been named winners of Grand Challenges Explorations, an initiative funded by Bill & Melinda Gates Foundation.
Their project, "Radioimmunotherapy in patients on anti-retroviral therapy for HIV cure," involves using radioimmunotherapy...
Two reseachers at Albert Einstein College of Medicine of Yeshiva University have found that our 98.6 Degrees
Fahrenheit (37 Degrees Celsius) body temperature strikes a perfect balance: warm enough to ward off
fungal infection but not so hot that we need to eat nonstop to maintain our metabolism...
On 26 May 2010, the first American Society for Microbiology postdoctoral chapter was approved at the ASM
council meeting. The chapter was proposed by postdoctoral scientists at the Wadsworth Center, New York
State Department of Health and Albany Medical College with the support of the ASM Eastern New York...
How vulnerable are we to bioterrorism? Arturo Casadevall, M.D., Ph.D., chair of microbiology and
immunology at Einstein and deputy director of the Northeast Biodefense Center, discusses the progress
and the barriers in the perpetual fight against biological attacks - by man and by nature...
With this issue, ASM launches a new, interdisciplinary journal designed to accommodate the universe
of microbiology and its allied disciplines under one roof. While perusing the pages of this first issue of
mBio, one will note that there are articles addressing a myriad of questions in virology, bacteriology...
Tiny, melanin-covered nanoparticles may protect bone marrow from the harmful effects of radiation therapy,
according to scientists at Albert Einstein College of Medicine of Yeshiva University who successfully tested
the strategy in mouse models. Infusing these particles into human patients may hold promise in the future...
On Tuesday, February 16, nearly 250 members of the Einstein community gathered in Robbins Auditorium
for the fourth Marshall S. Horwitz Prize Lecture. Delivering this year's lecture was Dr. Arturo Casadevall,
professor and Leo and Julia Forchheimer Chair in Microbiology & Immunology, who received this year's...
BBC News interviews Arturo Casadevall, M.D., Ph.D., on his assertion that the U.S. Select Agents and Toxins
List restrictions are too rigorous, preventing vital work on vaccines. Dr. Casadevall and Stanford's David Relman
argue in a paper in Nature Reviews Microbiology that the regulations should be relaxed and list reduced to...
The fact that they eat a lot - and often - may explain why most people and other mammals are protected from
the majority of fungal pathogens, according to research from Albert Einstein College of Medicine of
Yeshiva University. The research, published in The Journal of Infectious Diseases, showed that the elevated...
Researchers at Albert Einstein College of Medicine of Yeshiva University have identified two small proteins
fragments that could be developed into an anthrax vaccine that may cause fewer side effects than the current
vaccine. The research is significant because anthrax is considered a major bioterrorism threat. The current...
Dr. Arturo Casadevall was named founding editor-in-chief of mBio, a new, broad-scope, online-only, open-
access journal launched by the American Academy of Microbiology in conjunction with the American Society
of Microbiology. The goal of the publication will be to publish the best research in microbiology and allied...
A consortium of research centers in teh Tri-state Region, including Albert Einstein College of Medicine of
Yeshiva University, has received a $46 million grant to conduct research on emerging infectious diseases.The
grant, from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National...
Scientists at Albert Einstein College of Medicine of Yeshiva University have piggybacked antibodies onto
radioactive payloads to deliver doses of radiation that selectively target and destroy microbial and HIV-infected
cell. The experimental treatment - called radioimmunotherapy, or RIT - holds promise for treating various...
Researchers at Albert Einstein College of Medicine of Yeshiva University hav discovered how a deadly
microbe evades the human immune system and causes disease. The study, published in the journal Proceedings
of the National Academy of Sciences (PNAS), may help scientists develop new therapies or vaccines against...
NPR's "Science Friday" includes Dr. Arturo Casadevall, Forchheimer professor and chair of microbiology &
immunology at Einstein, on a panel of nationally acclaimed scientists to discuss the many facets of fungi...
Pain Therapeutics, Inc. recently announced the successful completion of its first clinical study utilizing a novel
melanoma treatment, which the company licensed from Albert Einstein College of Medicine of Yeshiva University.
The treatment consisted of dosing patients with a monoclonal antibody labeled with a radioisotope...
